vs
亚什兰（ASH）与STEPAN CO（SCL）财务数据对比。点击上方公司名可切换其他公司
STEPAN CO的季度营收约是亚什兰的1.6倍（$604.5M vs $386.0M），STEPAN CO净利率更高（3.3% vs -3.1%，领先6.4%），STEPAN CO同比增速更快（1.9% vs -4.7%），过去两年STEPAN CO的营收复合增速更高（4.2% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
斯特潘公司是一家美国特种化学品制造商，总部位于伊利诺伊州诺斯布鲁克，1932年由小阿尔弗雷德·C·斯特潘创立，现有约2000名员工，目前由创始人的孙子小F·奎因·斯特潘执掌。该公司是全球最大的阴离子表面活性剂商品生产商，产品用于提升洗涤剂、洗发水、牙膏及化妆品的起泡与清洁能力。
ASH vs SCL — 直观对比
营收规模更大
SCL
是对方的1.6倍
$386.0M
营收增速更快
SCL
高出6.6%
-4.7%
净利率更高
SCL
高出6.4%
-3.1%
两年增速更快
SCL
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $604.5M |
| 净利润 | $-12.0M | $19.7M |
| 毛利率 | 27.2% | 10.7% |
| 营业利润率 | -1.6% | 4.7% |
| 净利率 | -3.1% | 3.3% |
| 营收同比 | -4.7% | 1.9% |
| 净利润同比 | 92.7% | — |
| 每股收益（稀释后） | $-0.26 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHSCL
| Q1 26 | — | $604.5M | ||
| Q4 25 | $386.0M | $553.9M | ||
| Q3 25 | $477.0M | $590.3M | ||
| Q2 25 | $463.0M | $594.7M | ||
| Q1 25 | $479.0M | $593.3M | ||
| Q4 24 | $405.0M | $525.6M | ||
| Q3 24 | $521.0M | $546.8M | ||
| Q2 24 | $544.0M | $556.4M |
净利润ASHSCL
| Q1 26 | — | $19.7M | ||
| Q4 25 | $-12.0M | $5.0M | ||
| Q3 25 | $31.0M | $10.8M | ||
| Q2 25 | $-742.0M | $11.3M | ||
| Q1 25 | $31.0M | $19.7M | ||
| Q4 24 | $-165.0M | $3.4M | ||
| Q3 24 | $17.0M | $23.6M | ||
| Q2 24 | $6.0M | $9.5M |
毛利率ASHSCL
| Q1 26 | — | 10.7% | ||
| Q4 25 | 27.2% | 9.3% | ||
| Q3 25 | 33.3% | 12.0% | ||
| Q2 25 | 28.5% | 12.1% | ||
| Q1 25 | 30.7% | 12.7% | ||
| Q4 24 | 27.4% | 10.8% | ||
| Q3 24 | 33.2% | 13.8% | ||
| Q2 24 | 34.2% | 12.5% |
营业利润率ASHSCL
| Q1 26 | — | 4.7% | ||
| Q4 25 | -1.6% | 1.9% | ||
| Q3 25 | 12.8% | 3.7% | ||
| Q2 25 | -152.9% | 3.0% | ||
| Q1 25 | 10.6% | 4.8% | ||
| Q4 24 | -44.2% | 1.5% | ||
| Q3 24 | 6.1% | 4.4% | ||
| Q2 24 | -11.2% | 3.4% |
净利率ASHSCL
| Q1 26 | — | 3.3% | ||
| Q4 25 | -3.1% | 0.9% | ||
| Q3 25 | 6.5% | 1.8% | ||
| Q2 25 | -160.3% | 1.9% | ||
| Q1 25 | 6.5% | 3.3% | ||
| Q4 24 | -40.7% | 0.6% | ||
| Q3 24 | 3.3% | 4.3% | ||
| Q2 24 | 1.1% | 1.7% |
每股收益（稀释后）ASHSCL
| Q1 26 | — | $0.86 | ||
| Q4 25 | $-0.26 | $0.22 | ||
| Q3 25 | $0.83 | $0.47 | ||
| Q2 25 | $-16.21 | $0.50 | ||
| Q1 25 | $0.65 | $0.86 | ||
| Q4 24 | $-3.50 | $0.14 | ||
| Q3 24 | $0.34 | $1.03 | ||
| Q2 24 | $0.12 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | — |
| 总债务越低越好 | $1.4B | $328.4M |
| 股东权益账面价值 | $1.9B | $1.2B |
| 总资产 | $4.5B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | $304.0M | $132.7M | ||
| Q3 25 | $215.0M | $118.5M | ||
| Q2 25 | $207.0M | $88.9M | ||
| Q1 25 | $168.0M | $107.5M | ||
| Q4 24 | $219.0M | $99.7M | ||
| Q3 24 | $300.0M | $147.3M | ||
| Q2 24 | $399.0M | $124.7M |
总债务ASHSCL
| Q1 26 | — | $328.4M | ||
| Q4 25 | $1.4B | $626.7M | ||
| Q3 25 | $1.4B | $655.5M | ||
| Q2 25 | $1.4B | $658.0M | ||
| Q1 25 | $1.3B | $659.3M | ||
| Q4 24 | $1.3B | $625.4M | ||
| Q3 24 | $1.3B | $688.5M | ||
| Q2 24 | $1.3B | $657.1M |
股东权益ASHSCL
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $1.9B | $1.2B | ||
| Q1 25 | $2.6B | $1.2B | ||
| Q4 24 | $2.6B | $1.2B | ||
| Q3 24 | $2.9B | $1.2B | ||
| Q2 24 | $3.0B | $1.2B |
总资产ASHSCL
| Q1 26 | — | $2.3B | ||
| Q4 25 | $4.5B | $2.4B | ||
| Q3 25 | $4.6B | $2.4B | ||
| Q2 25 | $4.6B | $2.4B | ||
| Q1 25 | $5.2B | $2.4B | ||
| Q4 24 | $5.2B | $2.3B | ||
| Q3 24 | $5.6B | $2.4B | ||
| Q2 24 | $5.7B | $2.3B |
负债/权益比ASHSCL
| Q1 26 | — | 0.28× | ||
| Q4 25 | 0.74× | 0.50× | ||
| Q3 25 | 0.73× | 0.53× | ||
| Q2 25 | 0.73× | 0.53× | ||
| Q1 25 | 0.52× | 0.55× | ||
| Q4 24 | 0.51× | 0.53× | ||
| Q3 24 | 0.47× | 0.56× | ||
| Q2 24 | 0.45× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | — |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | $125.0M | $60.0M | ||
| Q3 25 | $40.0M | $69.8M | ||
| Q2 25 | $115.0M | $11.2M | ||
| Q1 25 | $9.0M | $6.9M | ||
| Q4 24 | $-30.0M | $68.3M | ||
| Q3 24 | $80.0M | $22.7M | ||
| Q2 24 | $127.0M | $29.5M |
自由现金流ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | $25.4M | ||
| Q3 25 | $6.0M | $40.2M | ||
| Q2 25 | $95.0M | $-14.4M | ||
| Q1 25 | $-12.0M | $-25.8M | ||
| Q4 24 | $-53.0M | $32.1M | ||
| Q3 24 | $42.0M | $-4.0M | ||
| Q2 24 | $98.0M | $-208.0K |
自由现金流率ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | 4.6% | ||
| Q3 25 | 1.3% | 6.8% | ||
| Q2 25 | 20.5% | -2.4% | ||
| Q1 25 | -2.5% | -4.3% | ||
| Q4 24 | -13.1% | 6.1% | ||
| Q3 24 | 8.1% | -0.7% | ||
| Q2 24 | 18.0% | -0.0% |
资本支出强度ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 6.3% | ||
| Q3 25 | 7.1% | 5.0% | ||
| Q2 25 | 4.3% | 4.3% | ||
| Q1 25 | 4.4% | 5.5% | ||
| Q4 24 | 5.7% | 6.9% | ||
| Q3 24 | 7.3% | 4.9% | ||
| Q2 24 | 5.3% | 5.3% |
现金转化率ASHSCL
| Q1 26 | — | — | ||
| Q4 25 | — | 11.99× | ||
| Q3 25 | 1.29× | 6.44× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | 0.29× | 0.35× | ||
| Q4 24 | — | 20.38× | ||
| Q3 24 | 4.71× | 0.96× | ||
| Q2 24 | 21.17× | 3.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
